Craig Hettenbach
Stock Analyst at Morgan Stanley
(2.21)
# 2,501
Out of 4,814 analysts
288
Total ratings
56.72%
Success rate
-1.73%
Average return
Main Sectors:
Stocks Rated by Craig Hettenbach
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UHS Universal Health Services | Initiates: Equal-Weight | $200 | $174.51 | +14.61% | 1 | Mar 26, 2025 | |
| THC Tenet Healthcare | Initiates: Overweight | $165 | $121.51 | +35.79% | 1 | Mar 26, 2025 | |
| VEEV Veeva Systems | Maintains: Underweight | $195 → $201 | $220.66 | -8.91% | 7 | Mar 6, 2025 | |
| HIMS Hims & Hers Health | Downgrades: Equal-Weight | $42 → $60 | $27.22 | +120.43% | 2 | Feb 18, 2025 | |
| ARDT Ardent Health Partners | Maintains: Overweight | $24 → $22 | $12.51 | +75.86% | 2 | Jan 21, 2025 | |
| AMWL American Well | Maintains: Equal-Weight | $20 → $11 | $6.99 | +50.21% | 5 | Dec 17, 2024 | |
| GDRX GoodRx Holdings | Maintains: Equal-Weight | $7 → $6 | $4.48 | +34.08% | 2 | Dec 17, 2024 | |
| HCA HCA Healthcare | Maintains: Equal-Weight | $406 → $355 | $334.38 | +6.17% | 2 | Dec 17, 2024 | |
| SLAB Silicon Laboratories | Maintains: Equal-Weight | $123 → $97 | $89.97 | +7.81% | 14 | Nov 5, 2024 | |
| DH Definitive Healthcare | Maintains: Equal-Weight | $9 → $5 | $2.53 | +98.02% | 12 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $96 → $114 | $55.98 | +103.64% | 24 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $62 → $57 | $19.39 | +193.97% | 19 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $81 | $38.53 | +110.23% | 23 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $35 | $53.20 | -34.21% | 4 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $12.35 | +45.75% | 4 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $208 → $185 | $57.60 | +221.18% | 23 | Feb 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $162 → $167 | $127.83 | +30.64% | 23 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $42 → $42 | $65.13 | -35.51% | 25 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $165 → $159 | $163.77 | -2.91% | 2 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $125 | $67.28 | +85.79% | 3 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $72 | $170.99 | -57.72% | 22 | Dec 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $193 → $195 | $148.36 | +31.44% | 3 | Oct 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $515 → $488 | $454.11 | +7.46% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $297 → $296 | $322.37 | -8.18% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $273 → $368 | $217.06 | +69.54% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $513 | $264.38 | +94.04% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $321 → $275 | $330.19 | -16.71% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $94 → $88 | $60.68 | +45.02% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | n/a | $34.25 | - | 11 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $173 → $185 | $49.37 | +274.72% | 2 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $190 → $213 | $170.77 | +24.73% | 19 | Apr 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $53 → $58 | $68.67 | -15.54% | 12 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $101 → $117 | $176.27 | -33.62% | 15 | Jun 16, 2020 |
Universal Health Services
Mar 26, 2025
Initiates: Equal-Weight
Price Target: $200
Current: $174.51
Upside: +14.61%
Tenet Healthcare
Mar 26, 2025
Initiates: Overweight
Price Target: $165
Current: $121.51
Upside: +35.79%
Veeva Systems
Mar 6, 2025
Maintains: Underweight
Price Target: $195 → $201
Current: $220.66
Upside: -8.91%
Hims & Hers Health
Feb 18, 2025
Downgrades: Equal-Weight
Price Target: $42 → $60
Current: $27.22
Upside: +120.43%
Ardent Health Partners
Jan 21, 2025
Maintains: Overweight
Price Target: $24 → $22
Current: $12.51
Upside: +75.86%
American Well
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $20 → $11
Current: $6.99
Upside: +50.21%
GoodRx Holdings
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $7 → $6
Current: $4.48
Upside: +34.08%
HCA Healthcare
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $406 → $355
Current: $334.38
Upside: +6.17%
Silicon Laboratories
Nov 5, 2024
Maintains: Equal-Weight
Price Target: $123 → $97
Current: $89.97
Upside: +7.81%
Definitive Healthcare
Aug 6, 2024
Maintains: Equal-Weight
Price Target: $9 → $5
Current: $2.53
Upside: +98.02%
Feb 7, 2023
Maintains: Equal-Weight
Price Target: $96 → $114
Current: $55.98
Upside: +103.64%
Jun 10, 2022
Maintains: Overweight
Price Target: $62 → $57
Current: $19.39
Upside: +193.97%
Jun 10, 2022
Maintains: Overweight
Price Target: $85 → $81
Current: $38.53
Upside: +110.23%
May 18, 2022
Maintains: Equal-Weight
Price Target: $55 → $35
Current: $53.20
Upside: -34.21%
Mar 28, 2022
Maintains: Overweight
Price Target: $20 → $18
Current: $12.35
Upside: +45.75%
Feb 3, 2022
Maintains: Overweight
Price Target: $208 → $185
Current: $57.60
Upside: +221.18%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $162 → $167
Current: $127.83
Upside: +30.64%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $42 → $42
Current: $65.13
Upside: -35.51%
Dec 17, 2021
Maintains: Equal-Weight
Price Target: $165 → $159
Current: $163.77
Upside: -2.91%
Dec 13, 2021
Maintains: Overweight
Price Target: $115 → $125
Current: $67.28
Upside: +85.79%
Dec 10, 2021
Maintains: Overweight
Price Target: $57 → $72
Current: $170.99
Upside: -57.72%
Oct 27, 2021
Maintains: Underweight
Price Target: $193 → $195
Current: $148.36
Upside: +31.44%
Aug 31, 2021
Maintains: Overweight
Price Target: $515 → $488
Current: $454.11
Upside: +7.46%
Aug 31, 2021
Maintains: Overweight
Price Target: $297 → $296
Current: $322.37
Upside: -8.18%
Aug 31, 2021
Maintains: Overweight
Price Target: $273 → $368
Current: $217.06
Upside: +69.54%
Aug 31, 2021
Maintains: Overweight
Price Target: $500 → $513
Current: $264.38
Upside: +94.04%
Aug 31, 2021
Maintains: Overweight
Price Target: $321 → $275
Current: $330.19
Upside: -16.71%
Aug 31, 2021
Maintains: Overweight
Price Target: $94 → $88
Current: $60.68
Upside: +45.02%
Aug 3, 2021
Upgrades: Equal-Weight
Price Target: n/a
Current: $34.25
Upside: -
May 7, 2021
Maintains: Overweight
Price Target: $173 → $185
Current: $49.37
Upside: +274.72%
Apr 8, 2021
Downgrades: Equal-Weight
Price Target: $190 → $213
Current: $170.77
Upside: +24.73%
Feb 11, 2021
Maintains: Equal-Weight
Price Target: $53 → $58
Current: $68.67
Upside: -15.54%
Jun 16, 2020
Maintains: Equal-Weight
Price Target: $101 → $117
Current: $176.27
Upside: -33.62%